tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OCX Stock Latest News

OncoCyte files to sell 10.61M shares of common stock for holders
The FlyOncoCyte files to sell 10.61M shares of common stock for holders
3d ago
OCX
OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing
PremiumRatings
OncoCyte’s Strategic Positioning and Growth Potential in Transplant Rejection Testing
7d ago
OCX
OncoCyte initiated with a Buy at Lake Street
PremiumThe Fly
OncoCyte initiated with a Buy at Lake Street
7d ago
OCX
OncoCyte Corp’s Positive Earnings Call Highlights Growth
PremiumCompany Announcements
OncoCyte Corp’s Positive Earnings Call Highlights Growth
9d ago
OCX
OncoCyte reports Q4 EPS ($1.93) vs. ($1.96) last year
PremiumThe Fly
OncoCyte reports Q4 EPS ($1.93) vs. ($1.96) last year
9d ago
OCX
Positive Outlook on OncoCyte’s Stock Due to Strategic Launch and Financial Management
PremiumRatingsPositive Outlook on OncoCyte’s Stock Due to Strategic Launch and Financial Management
10d ago
OCX
Oncocyte Corp Reports 2024 Success and 2025 Growth Plans
Premium
Company Announcements
Oncocyte Corp Reports 2024 Success and 2025 Growth Plans
10d ago
OCX
OCX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OCX Upcoming Earnings Report: What to Expect?
13d ago
OCX
OncoCyte Announces Executive Promotions and Compensation Changes
PremiumCompany Announcements
OncoCyte Announces Executive Promotions and Compensation Changes
24d ago
8K
OCX
OncoCyte’s $29.1M Funding Through Securities Agreements
PremiumCompany Announcements
OncoCyte’s $29.1M Funding Through Securities Agreements
2M ago
8K
OCX
OncoCyte prices $29.1M equity offering
PremiumThe Fly
OncoCyte prices $29.1M equity offering
2M ago
BIO
OCX
OncoCyte appoints Billings as consulting CMO
PremiumThe Fly
OncoCyte appoints Billings as consulting CMO
3M ago
OCX
OncoCyte announces publication of DetermaCNI assay data
PremiumThe FlyOncoCyte announces publication of DetermaCNI assay data
4M ago
OCX
OncoCyte announces VitaGraft data published in journal
Premium
The Fly
OncoCyte announces VitaGraft data published in journal
4M ago
OCX
OncoCyte Corp Reports Q3 2024 Earnings and Strategic Updates
Premium
Company Announcements
OncoCyte Corp Reports Q3 2024 Earnings and Strategic Updates
5M ago
OCX
OncoCyte reports Q3 EPS (98c), consensus (44c)
PremiumThe Fly
OncoCyte reports Q3 EPS (98c), consensus (44c)
5M ago
OCX
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
OCX
OncoCyte files to sell 3.46M shares of common stock for holders
PremiumThe Fly
OncoCyte files to sell 3.46M shares of common stock for holders
6M ago
OCX
OncoCyte Shareholders Approve Incentive Plan and Meeting Adjournment
PremiumCompany Announcements
OncoCyte Shareholders Approve Incentive Plan and Meeting Adjournment
6M ago
8K
OCX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
OCX
BPTH
OncoCyte’s DetermaIO predicts response to Atezolizumab in Phase 2 trial
Premium
The Fly
OncoCyte’s DetermaIO predicts response to Atezolizumab in Phase 2 trial
6M ago
OCX
OncoCyte Secures Funding Through Private Share Sale
Premium
Company Announcements
OncoCyte Secures Funding Through Private Share Sale
6M ago
8K
OCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >